Transfer Factor Plus And Cancer
4162019 In addition to direct sales from MLM distributors customers can now buy 4Life Transfer Factor from retailers like Amazon eBay or Walgreens.
Transfer factor plus and cancer. 9172019 However the transfer factor doesnt seem to affect survival in most people with lung cancer. 4Life Research USA LLC 4Life Holdings LLC 9850 S 300 W Sandy UT 84070-3262. Today 87 months later there has been no recurrence and her father says his problem now is that she is too intelligent and asking him questions all the time and playing non stop.
Cancer Tumor Stage 1. The 4Life Transfer Factor PLUS Tri-Factor Formula was recommended to me by a good friend because my mother is currently battling breast cancer. It is a tri-factor formula that contains OvoFactor UltraFactor XF and NanoFactor extracts.
My friends mother was informed that she had 6 months to live after the. Thirty-five selected patients with advanced recurrent cancer who were not suitable for further conventional therapy were treated with transfer factor. Boosting the immune system to fight cancer.
Melanoma a type of skin cancer. Hastings RC Job CK. This review of the literature regarding the clinical effort of transfer factor in malignancy leads to the conclusion that transfer factor might not be an effective therapy of cancer.
It claims to boost the activity of natural killer cells in your body. If it does have efficacy in certain malignancies it is unlikely that it will alone have dramatic effects in substantial numbers of patients. It claims to educate enhance and balance the immune system.
Advanced Immune Support 24 hours a day 7 days a week. The objective of this study was to utilize transfer factor to stimulate cell-mediated immunity to specific tumor antigens in cancer patients. 2112020 Transfer Factor Memorial Sloan Kettering Cancer Center COVID-19 Vaccine Available to MSK Patients Who Live in New York State As of 313 vaccines are offered to MSK cancer patients age 18-59 who are in treatment or have had a provider visit since 1118.
